Company Overview and News


Add BTX
to your dashboard

Headline News

BioTime's (BTX) CEO Michael West on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Greetings, and welcome to BioTime, Inc. Third Quarter 2017 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. A replay of the conference call will be available for 7 business days beginning about 2 hours after the conclusion of the live call by calling toll free from U.S. or Canada at 1844-512-2921. International callers, 1412-317-6671. User conference ID number or pin 136-71848. (7-1)

Your Daily Pharma Scoop: AZN's Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?

2017-10-18 seekingalpha
This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (389-1)

BRIEF-Biotime announces first patient in U.S. clinical trial treated for facial volume deficit

2017-10-11 reuters
* Biotime Inc - ‍Biotime expects to file CE Mark application by end of this year with possible approval and launch next year​ (9-1)

3 Things In Biotech You Should Learn Today: October 3, 2017

2017-10-03 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. (42-3)

3 Things In Biotech You Should Learn Today: September 26, 2017

2017-09-26 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. (197-2)

BRIEF-BioTime announces positive data from Renevia pivotal trial

2017-09-26 reuters
* BioTime Inc - ‍preliminary data for five patients indicates an average retention of 64% of transplanted volume at 18 months​ Source text for Eikon: Further company coverage: (9-0)

BRIEF-BioTime ‍announced conclusion of challenge to two key patents before European patent office opposition division​

2017-09-14 reuters
* BioTime Inc - ‍Announced conclusion of challenge to two key patents before European patent office opposition division​ Source text for Eikon: Further company coverage: (1-2)

ALR's Insider Weekly: Heavy Insider Activity In This Overlooked Biotech & More

2017-08-07 seekingalpha
When insiders are willing to put their own skin in the game, we think it's a positive sign and is worth digging further. (0-1)

BioTime's (BTX) Management on Q2 2017 Results - Earnings Call Transcript

2017-08-03 seekingalpha
Greetings and welcome to the BioTime Second Quarter 2017 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to introduce your host for today's conference, Doug Sherk. Thank you may begin.

3 Things In Biotech You Should Learn Today: July 28, 2017

2017-07-28 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest that is dedicated to helping you keep up with the latest news coming out of the biotech and pharmaceutical research worlds.

3 Things In Biotech You Should Learn Today: July 19, 2017

2017-07-19 seekingalpha
Welcome to another edition of "3 Things in Biotech You Should Learn Today," a daily digest dedicated to helping you unearth data from the world of biotech and pharmaceutical research.

3 Things In Biotech You Should Learn Today: June 22, 2017

2017-06-22 seekingalpha
Welcome to another edition of "3 Things in Biotech You Should Learn Today," a daily digest highlighting recent news from the pharma and biotech world that you may not have seen. (0-1)

CUSIP: 09066L105